Beactica Therapeutics
Gun Stenberg has extensive work experience as a senior scientist at Beactica AB from 2009- present. Prior to this, they served as an Associate Professor and Researcher at Uppsala Biomedical Center from 1995-2009. Additionally, Gun Stenberg worked as an Associate Professor at Uppsala Universitet from 2001-2007 and as a University Lecturer at Uppsala University from 2000-2007.
Gun Stenberg obtained a Ph.D. in Biochemistry from Stockholm University. Gun pursued their Ph.D. degree from 1986 to 1991.
This person is not in any teams
Beactica Therapeutics
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Beactica’s approach is centered around targeting disease proteins with synthetic lethality vulnerabilitiesby applying its molecular interaction-based drug discovery engine to generate novel small molecule across synergistic modalities, including allosteric modulators and targeted protein degraders (PROTACs). Beactica deliver value to patients and shareholders by advancing its programmes into early clinical trials.